Improving diagnostics of respiratory diseases and boosting the COMAC MEDICAL Ltd. competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device

Lesley Katie Seymour

LACE-Bio-II: Identification, Validation and Implementation of Prognostic and/or P

Trachea, bronchus and lung

Pathology

Denise A Galloway

Novel Pathogen Associated Cancers (PQ12)

Trachea, bronchus and lung Non-Hodgkin lymphoma Hodgkin lymphoma Colorectum

Carlo M Croce

MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment

Trachea, bronchus and lung Prostate Ovary Colorectum Breast

Paul Joseph Brennan

One-carbon metabolism biomarkers and lung cancer risk

Trachea, bronchus and lung

Investigator from Adaptix Ltd

Tomosynthesis is a low-dose alternate to has CT already transformed Breast Imaging, our vision is to reduce the costs, further enhance sensitivity and reduce dose, and transform portability.

Trachea, bronchus and lung Breast

Radiation Oncology

Investigator from Aristotle University of Thessaloniki

Multidisciplinary tools for improving the efficacy of public prevention measures against smoking

Trachea, bronchus and lung

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Hematology and hematologic malignancies Pathology

Simon D Spivack

Risk for Lung Cancer Asthma and COPD; Integrating Clinical and Airway Biomarker

Trachea, bronchus and lung

Michael James Hassett

Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs

Trachea, bronchus and lung Prostate Colorectum Breast